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1  | INTRODUC TION
Atherosclerosis is a chronic and progressive disease with a bidirec-
tional interaction between lipids and inflammation as a major feature. 
The underlying pathological process is lipid accumulation leading to 
monocyte, macrophage, and T-cell recruitment, and this slowly pro-
gressing chronic disorder of the arteries can ultimately lead to intra-
vascular thrombosis and plaque destabilization with manifestation 
of acute ischemic events such as myocardial infarction and ischemic 
stroke. Atherosclerosis-related cardiovascular disease (CVD) is the 
leading cause of death in Western countries (Lloyd-Jones, 2010; 
Woollard, 2013).
The liver is a central regulator of lipid metabolism and is also re-
ported to be involved in the regulation of the inflammatory state 
during metabolic disturbances such as fatty liver disease and ath-
erosclerosis (Kleemann & Kooistra, 2005; Rein et al., 2006; Thakur 
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Abstract
Chicken protein hydrolysates (CPHs) generated from rest raw materials through en-
zymatic hydrolysis using Corolase PP or Alcalase were shown to reduce inflammation 
and stimulate hepatic mitochondrial fatty acid oxidation in high-fat-fed mice. This 
study investigates the effect of CPH diets in atherosclerosis-prone apolipoprotein 
E-deficient (Apoe−/−) mice. Apoe−/− mice were divided into three groups of 12 animals 
and fed high-fat diets with casein (control), Alcalase CPH, or Corolase PP CPH. After 
12 weeks, mice were sacrificed, blood samples were collected, and aorta was dis-
sected for subsequent én face analysis. Mice fed Corolase PP CPH but not Alcalase 
CPH had significantly lower % atherosclerotic plaque area in the aortic arch com-
pared to controls (p = .015 and p = .077, respectively). Plasma and liver cholesterol 
and triacylglycerol remained constant, but levels of the fatty acid C20:5n-3 were in-
creased, accompanied by an elevated delta-5 desaturase index in both CPHs groups. 
Moreover, a significant reduction of plasma MCP-1 was detected in Corolase PP CPH 
compared to control. Overall, our data show that protein hydrolysates from chicken 
reduced atherosclerosis and attenuated systemic risk factors related to atheroscle-
rotic disorders, not related to changes in the level of plasma cholesterol.
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et al., 2012). Indeed, dietary cholesterol absorbed by the liver con-
tributes to inflammation (Kleemann et al., 2007). Additionally, there 
is growing evidence of mitochondrial dysfunction accompanied by 
increased oxidative stress in the pathogenesis of atherosclerosis 
(Lakshmi, Padmaja, Kuppusamy, & Kutala, 2009; Madamanchi & 
Runge, 2007). The growing epidemic of obesity-related diseases as-
sociated with a metabolic phenotype characterized by dyslipidemia 
may further contribute to an increased risk of atherosclerosis asso-
ciated with CVD.
Dietary habits are reported to reduce some risk factors involved 
in the initiation and progression of atherosclerosis, such as total cho-
lesterol, LDL-cholesterol, triacylglycerol (TAG), and inflammation. 
Seafood consumption is considered health beneficial as it lowers 
plasma lipids and attenuates inflammation (Parolini et al., 2014). This 
is possibly linked to an increased long-chain n-3 PUFAs content of 
eicosapentaenoic acid (EPA, C20:5n-3) and docosahexaenoic acid 
(DHA, C22:6n-3) and lowering of n-6 PUFAs such as arachidonic 
acid (AA; C20:4n-6). Interestingly, it has also been reported that low 
levels of circulating eicosatetraenoic acid (C20:4n-3) and high levels 
of vaccenic acid (C18:1n-7) are associated with chronic heart failure 
(Oie et al., 2011).
It has lately been suggested that some of the advantages of 
seafood on health could arise from peptides released during di-
gestion, and studies in animals have shown that a number of fish 
protein hydrolysates have lipid lowering and antioxidant effect 
(Bjorndal et al., 2013; Wergedahl, Gudbrandsen, Rost, & Berge, 
2009; Wergedahl et al., 2004). We have previously reported that 
a salmon protein hydrolysate has a protective role in atheroscle-
rotic development through mechanisms linked to inhibition of 
inflammation (Parolini et al., 2014). Recently, we have also found 
that both the oil and the protein fraction from Antartic krill 
(Euphausia superba) inhibited plaque development in apolipopro-
tein E (Apoe−/−) knockout mice (Parolini et al., 2017). Moreover, 
we have demonstrated that a fish protein hydrolysate influenced 
hepatic fatty acid metabolism and fatty acid composition indicat-
ing that effects on fatty acid metabolism are important for the bio-
activity of protein hydrolysates (Bjorndal et al., 2013; Wergedahl 
et al., 2009, 2004). Protein from vegetables such as soy, pea, and 
lupin exerts both TAG and cholesterol-lowering effects in animals 
as well as in human studies (Choi et al., 2011; Lee et al., 2009; 
Morita et al., 1997; Rigamonti et al., 2010). Soy milk and its hydro-
lysate were also anti-obesogenic in mice (Choi et al., 2011), and 
a dietary single-cell protein produced by bacteria reduced fatty 
liver in obese Zucker rats (Gudbrandsen et al., 2008). Interestingly, 
while high-protein chicken diets have been reported to increase 
energy intake in rodents (Liisberg et al., 2016), a chicken collagen 
hydrolysate was shown to exert a strong angiotensin-converting 
enzyme (ACE) inhibitory activity and antihypertensive effect as 
well as to protect from cardiovascular damage in spontaneously 
hypertensive rats (Saiga et al., 2008; Zhang et al., 2010). Thus, the 
amount and type of dietary protein and/or hydrolysates may influ-
ence systemic inflammation, blood lipid concentrations, and blood 
pressure and may also have anti-obesogenic properties.
In this study, we investigated the anti-atherosclerotic potential 
of two chicken protein hydrolysates, previously shown to increase 
mitochondrial fatty acid oxidation and reduce systemic inflam-
mation (Aloysius et al., 2018), on atherosclerotic development in 
apolipoprotein E knockout (Apoe −/−) mice, characterized by hyper-
lipidaemia and susceptibility to atherosclerosis (Zhang, Reddick, 
Piedrahita, & Maeda, 1992).
2  | MATERIAL S AND METHODS
2.1 | Animals and diets
The animal study was conducted in accordance with the Ethical 
Guidelines for the Use of Animals in Research (The Norwegian 
National Research Ethics Committees). The protocol was ap-
proved by the Norwegian Food Authorities (Project no. 7618). 
Female Apoe−/− mice, between 5 and 6 weeks old, were purchased 
from Taconic (Ry, Denmark). Upon arrival, the mice were placed 
in open cages, four in each cage, and they were allowed to ac-
climatize to their surroundings for one week before start of the 
TA B L E  1   Nutrient composition of the diets in energy % (E%) and 
weight (g/1000 g)
Nutrients Casein Alcalase Corolase PP
Protein (E%) 17 17 17
Casein (g) 200 75 75
CPH (g)  125 125
Fat (E%) 41 41 41
Soy oil (g) 20 20 20
Lard (g) 190 190 190
Cholesterol (g) 2.2 2.2 2.2
Carbohydrate (E%) 42 42 42
Cornstarch (g) 100 100 100
Dyetrose (g) 50 50 50
Sucrose (g) 340 340 340

















Note: All ingredients were from Dyets inc. (Bethlehem, PA, USA), except 
cholesterol and tert-Butyl hydroquinone, which were purchased from 
Sigma-Aldrich (St. Louis, MO, USA).
Abbreviation: CPH, chicken protein hydrolysate.
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experiment. The mice were kept in a 12 hr light/dark cycle at a 
constant temperature (22 ± 2°C) and a relative humidity of 55% (± 
5%). During the acclimatization period, the mice had unrestricted 
access to chow diet and tap water. The cages were block rand-
omized to three different diets, 12 mice per diet. Mice were fed ad 
libitum, and diet was renewed every 2–3 days. Group 1 (Control) 
was fed a high-fat high-sucrose diet with 41 E% fat, including 
0.22% (w/w) cholesterol, and with casein (17 E%) as the protein 
source (Table 1). In group 2 (Alcalase group), 62.5% of the casein 
was replaced with CPH generated using the food grade commer-
cial enzyme Alcalase, while in group 3 (Corolase PP group) 62.5% 
of the casein was replaced with CPH generated using the food 
grade commercial enzyme Corolase PP. The CPHs were generated 
as previously published (Aloysius et al., 2018).
Mice were fasted for four hours and anaesthetized by inhalation 
of 2% isoflurane (Schering-Plough, Kent, UK) before sacrifice. The 
abdomen was opened in the midline, and EDTA blood was collected 
by cardiac puncture of the right ventricle and immediately chilled on 
ice. The samples were centrifuged, and plasma was stored at −80°C 
prior to analysis. The mice were perfused with 10 ml cold PBS in 
the left ventricle via 22-gauge needle and 10-ml syringe, with an in-
cision in the large liver lobe. Liver and adipose tissues (epididymal, 
perirenal, and subcutaneous white adipose tissue depots) were col-
lected, weighed, and immediately snap-frozen in liquid nitrogen and 
stored at −80°C until further analysis. The aorta was dissected from 
the heart to 3–5 mm after the iliac bifurcation, and adventitia tissue 
present was carefully removed. The heart was removed and aortas 
were fixed for 24 hr in 4% paraformaldehyde in PBS, transferred to 
PBS, and stored at 4°C.
2.2 | Én-face analysis
Aortas were dissected and stained according to Daugherty and 
Whitman (Daugherty & Whitman, 2003). In short, aortas were 
placed on a nonreflecting, black surface (a pad of 6 layers of para-
film covered with black vulcanized insulation tape), in a container 
filled with PBS. The aortas were opened longitudinally under a 
magnifier (Carl Zeiss OPMI pico) and pinned flat. Aortas were fixed 
in 70% ethanol for 5 min and stained in 0.25%–0.5% oil red O in 
isopropyl alcohol for 15 min. Samples were then destained in 80% 
ethanol for 3 min and rinsed under running water. Stained aortas 
were stored in PBS until imaging. Images were captured with a 
digital camera (Canon 5D Mark II). Assessment of % plaque area 
was performed using the software Image J (http://rsb.info.nih.
gov/ij/downl oad.html).
2.3 | Plasma and liver lipids and fatty acid 
composition
Liver lipids were extracted from frozen samples according to 
Bligh and Dyer (Bligh & Dyer, 1959), evaporated under nitrogen, 
and redissolved in isopropanol before analysis. Lipids from liver 
were measured enzymatically on a Cobas c 111 system (Roche 
Diagnostics GmbH) using the triacylglycerol (TRIGL) and cholesterol 
kit (CHOD-PAP) from Roche Diagnostics. Plasma lipids were meas-
ured enzymatically on a Hitachi 917 system (Roche Diagnostics 
GmbH) using the triacylglycerol (TRIGL), LDL-cholesterol (LDLC3), 
and cholesterol kit (CHOL2) from Roche Diagnostics (Diagnostic 
Systems GmbH), and the nonesterified fatty acid (NEFA) FS and 
Phospholipids FS kit from DiaSys (Diagnostics Systems GmbH). 
Total plasma fatty acid composition was analyzed as previously de-
scribed (Bjorndal et al., 2012).
2.4 | Plasma inflammatory markers
Plasma concentrations of interleukin 1α (IL-1α), IL-1β, IL-2, granulo-
cyte-macrophage colony-stimulating factor (GM-CSF), interferon 
gamma (IFN-γ), IL-6, monocyte chemotactic protein-1 (MCP-1), and 
tumor necrosis factor-α (TNF-α) were determined in animals per 
group using a custom-made multiplex MILLIPLEX MAP kit (Millipore 
Corp) according to manufacturer's protocol. The antibody-conju-
gated beads were allowed to react with the sample and a secondary 
antibody in a 96-well plate to form a capture sandwich immunoas-
say. Finally, the concentration of each marker in the solution was 
determined using a Bio-Plex 200 instrument, with Bio-Plex Manager 
Software 4.1 (Bio-Rad).
2.5 | Statistical analysis
Datasets were analyzed using Prism Software 6.0 (Graphpad 
Software). The results are shown as means of 12 animals per group 
with their standard deviations, unless otherwise stated. When a 
one-way ANOVA test gave a p-value < .05, Dunnett's multiple com-
parisons test was used to evaluate statistically significant difference 
between control and treatment groups. p-values < .05 in the post 
hoc tests were considered statistically significant. Weight change 
and feed intake over time were evaluated using repeated-measures 
two-way ANOVA (mixed-model).
3  | RESULTS
3.1 | Effects on atherosclerotic development and 
risk factors related to atherosclerotic disorders
Enzymatic hydrolysis of chicken rest raw material by Alcalase and 
Corolase PP generated protein hydrolysates that both affected the 
hepatic mitochondrial fatty acid oxidation in mice, while Corolase PP 
CPH had the strongest anti-inflammatory potential (Aloysius et al., 
2018). The data presented here show that after 12 weeks of high-
fat feeding, a significantly lower % plaque area (p = .015) was ob-
served in the aortic arch of Corolase PP CPH-treated Apoe−/− mice 
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F I G U R E  1   Effect of chicken protein 
hydrolysates (CPH) produced by Alcalase 
or Corolase PP on aortic plaque levels 
and plasma lipids in Apoe−/− mice fed a 
high-fat diet for 12 weeks. Representative 
images of oil red O stained whole aortas 
are shown (a). Ruler corresponds to 5 mm, 
and stippled lines indicate the division 
between arch and thoracic/abdominal 
aorta. en-face analysis was performed 
to quantify percent aortic surface area 
covered by atherosclerotic plaques in 
the aortic arch (b) or the thoracic and 
abdominal aorta (c). Levels of plasma total 
cholesterol level (d), plasma triacylglycerol 
(TAG, e), liver cholesterol (f), and liver 
TAG (g) were analyzed. Values are means 
with standard deviations (n = 10–12). 
Significant difference between groups 
was determined using one-way ANOVA 
with Dunnett's multiple comparisons test 
(*p < .05)
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compared to control (Figure 1a,b). Conversely, the én face analysis 
of aortic arch from Alcalase CPH-fed mice revealed only a trend to-
ward reduced atherosclerosis compared to control (p = .077). Low 
plaque levels were observed in the abdominal and thoracic aorta 
segments, and no significant difference between the diet groups 
was observed (Figure 1c). Interestingly, the plasma lipids, including 
total cholesterol and TAG, were not affected by CPH from Alcalase 
and Corolase PP (Figure 1d,e). Moreover, no changes in free choles-
terol, cholesterol-ester, NEFA, phospholipids, and LDL-cholesterol 
were found between the two protein hydrolysate groups and con-
trols (data not shown). Liver levels of TAG and cholesterol were not 
significantly different in mice fed the CPH diets compared to the 
control diet (Figure 1f,g).
The total plasma level of saturated fatty acids (SFAs) and mono-
unsaturated fatty acids (MUFAs) was not changed by the feeding 
of protein hydrolysates from Alcalase and Corolase PP, but an in-
crease in the levels of long-chain SFAs and MUFAs was observed in 
mice fed Alcalase CPH (C20:0, C22:0, C24:0, C20:1n-9, C20:1n-7, 
C22:1n-9, C22:1n-7, and C24:1n-9), and to a lesser degree in mice 
fed Corolase PP CPH ( C20:0, C22:0, and C22:1n-9) (Table S1). The 
estimated activity of stearoyl-CoA desaturase (SCD)-16 (C16:1n-7/
C16:0) and SCD-18 (C18:1n-9/C18:0) was not changed in either 
CHP group compared to control (Figure 2a,b). The plasma level of 
total polyunsaturated (PUFA) n-3, PUFA n-6, and PUFA n-9 was 
not changed in the two experimental animal groups (Table S1), 
but the Alcalase CPH reduced the level of total trans fatty acids. 
Noteworthily, the plasma level of C20:5n-3 was significantly in-
creased by the Alcalase and Corolase PP hydrolysates (Table S1), 
followed by a significantly increased delta 5-desaturase index 
(C20:5n-3/C20: 4n-3) and increased C20:5n-3/ C18:3n-3 ratio 
(Figure 2c,d). Moreover, the plasma level of C18:3n-6 was signifi-
cantly increased in the two experimental feeding groups whereas 
the level of C22:4n-6 was significantly decreased in the Corolase 
PP CPH group. The plasma level of C20:4 n-6 was not changed 
(Table S1).
The protein hydrolysate generated using Corolase PP reduced 
levels of plasma MCP-1 compared to control, while Alcalase CPH in-
creased the level of IL-2 compared to control (Figure 3).
3.2 | Effects of protein hydrolysates on body 
weight, feed intake, and adipose tissue mass
The body weight measured at baseline and at different time points 
during dietary treatment did not show any significant differences 
among the treatment groups (Figure 4a). The feed intake was meas-
ured for one week at three different time points and was not sig-
nificantly different between the groups (Figure 4b). However, both 
body weight and feed intake tended to be higher in the two hydro-
lysate groups compared to control, as did the weights of the vis-
ceral WAT depots (p = .06) (Figure 4c). Subcutaneous WAT and the 
ratio between subcutaneous and visceral WAT were not affected 
(Figure 4d-e).
4  | DISCUSSION
Protein hydrolysates may induce health benefits through anti-
oxidative (Raghavan & Kristinsson, 2008), immunomodulating 
(Zhang et al., 2010), antihypertensive (Saiga et al., 2008), and lipid 
lowering effects (Erdmann, Cheung, & Schroder, 2008). We have 
recently shown that a protein hydrolysate from salmon reduced 
atherosclerosis in Apoe−/− mice, most likely through effects on 
systemic inflammation (Parolini et al., 2014). Based on previous 
findings in mice, the amount and type of dietary protein and/or hy-
drolysates may influence fatty acid oxidation, hypolipidemia, and 
inflammation (Aloysius et al., 2018; Vik et al., 2015). Therefore, 
it was of interest to investigate a potential anti-atherosclerotic 
effect of protein hydrolysates from chicken previously shown to 
reduce plasma cytokine levels in a mouse obesity model (Aloysius 
et al., 2018). Indeed, we here show that Apoe−/− mice fed a high-
fat diet for twelve weeks, containing 12.5% (w/w) protein hydro-
lysates from chicken generated using the enzyme Corolase PP, 
developed less atherosclerotic plaques in the aortic arch com-
pared to controls.
Liver is the main organ regulating lipid and lipoprotein metabo-
lism, including plasma TAG and cholesterol levels. It was of interest 
that the plasma concentrations of cholesterol, TAG and NEFA, and 
the liver levels of cholesterol and TAG were not affected by CPH 
treatments in Apoe−/− mice (Figure 1). This was similar to previous 
findings in a C57BL/6 mice obesity model, where in vitro β-oxidation 
was slightly increased but without any effect on hepatic gene lev-
els or plasma lipid levels (Aloysius et al., 2018). However, a changed 
fatty acid composition was observed in Apoe−/− mice indicating 
some effect on fatty acid metabolism (Figure 2 and Table S1). After 
12 weeks of feeding with protein hydrolysates, the plasma levels of 
the anti-inflammatory fatty acids C20:4n-3 were significantly in-
creased in Corolase PP CPH-fed mice, while C20:5n-3 was signifi-
cantly increased by both the Alcalase CPH-diet and the Corolase 
PP CPH-diet. This was also reflected by an increased delta-5 desat-
urase index and an increased ratio of C20:5n-3/C18:3n-3 by both 
CPH diets, indicating an increase in desaturation and elongation 
processes. Although the plasma level of C18:3n-6 was reduced by 
the Alcalase CPH, no significant changes in the major pro-inflamma-
tory fatty acid, arachidonic acid (C20:4n-6), were found. Moreover, 
we have recently reported that low circulating eicosatetraenoic acid 
(C20:4n-3) is associated with heart failure (Oie et al., 2011), and this 
fatty acid was significantly increased by Corolase PP compared to 
control. The changed plasma fatty acid composition obtained with 
protein hydrolysates from Alcalase and especially Corolase PP could 
potentially have been due to increased mitochondrial fatty acid ox-
idation but was probably not influenced by peroxisomal fatty acid 
β-oxidation as previous findings indicated that the acyl-CoA oxidase 
1 (ACOX1) activity is constant in the liver of mice fed these two pro-
tein hydrolysates (Aloysius et al., 2018). Supporting this, peroxiso-
mal fatty acid oxidation is involved in chain shortening of long-chain 
fatty acid, and we observed an increased plasma level of long-chain 
(>C20:0) SFAs and MUFAs in CPH-fed Apoe−/− mice. Interestingly, 
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Alacalase CPH increased all measured long-chain SFA and MUFAs 
compared to control, while the Corolase PP CPH effect was less 
prominent, which could possibly have influenced the anti-athero-
genic properties of the diets.
Cytokines play a role in the progression of atherosclerosis, and it 
was of interest that feeding with Corolase PP CPHs, previously shown 
to reduce plasma cytokine levels in a C57BL/6 mice diet-induced obe-
sity model (Aloysius et al., 2018), was accompanied by a significantly 
F I G U R E  2   Estimated plasma fatty 
acid indices in Apoe−/− mice fed a high-fat 
diet. (a) The plasma stearoyl-coenzyme 
A desaturase 1 (SCD)-16 index. (b) The 
plasma SCD-18 index. (c) The plasma 
delta 5-desaturase index. (d) The plasma 
C20:5n-3/C18:3n-3 ratio. Means with 
standard deviations are shown (n = 12). 
Statistical difference between all 
diet groups was evaluated using one-
way ANOVA with Dunnett's multiple 
comparisons test (*p < .05, **p < .01)
F I G U R E  3   Plasma cytokine levels in Apoe−/− mice fed a casein high-fat diet (Control) or high-fat diets with different protein hydrolysates 
from chicken (Alcalase and Corolase PP). Interleukin IL-1α (a), IL-1β (b), IL-2 (c), granulocyte-macrophage colony-stimulating factor (GM-CSF) 
(d), interferon gamma (IFN-γ) (e), IL-6 (f), monocyte chemotactic protein 1 (MCP-1/CCL2) (g), and tumor necrosis factor alpha (TNF-α) (h) 
were measured by multiplex analysis. Means with standard deviations are shown (n = 7–8). Statistical difference between all diet groups was 
evaluated using one-way ANOVA with Dunnett's multiple comparisons test (*p < .05)
     |  7BJØRNDAL et AL.
reduced aortic plaque area, as seen by én-face analysis. The mechanism 
behind this effect is unclear, but Zhu et al. have shown that marine 
peptides may act as peroxisome proliferator-activated receptor ligands 
(PPAR) and exert anti-inflammatory effects (Zhu et al., 2010, 2017). 
In the current study, feeding with Corolase PP CPH only reduced the 
inflammatory marker MCP-1, while Alcalase CPH increased the plasma 
level of IL-2 (Figure 3). Thus, while this confirmed that Corolase PP CPH 
had a higher anti-inflammatory potential than Alcalase CPH, the plasma 
cytokine lowering was less prominent in high-fat fed Apoe−/− mice than 
previously seen in the mouse obesity model (Aloysius et al., 2018). This 
might have been due to the observed tendency to increased feed in-
take and increased visceral adipose tissue mass in the CPH-fed mice, 
which may have influenced plasma cytokine levels compared to con-
trol. It is possible that anti-inflammatory effects would have been de-
tected in the aortic lesions in the Corolase PP CPH group compared to 
control and that differences in potency between the Corolase PP CPH- 
and Alcalase CPH-diet could have been further documented, but un-
fortunately, we did not have enough material to perform this analysis.
5  | CONCLUSION
In summary, the present study has some limitation such as absence 
of data on inflammatory mediators within the aortic lesions, but it 
gives an indication that peptides generated from chicken rest raw 
materials may have a protective role in atherosclerotic development 
through mechanism linked to inhibition of inflammation, not directly 
related to plasma cholesterol level.
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